IP Library Assignment 027724/0097
Patent Assignment
Reel/Frame 027724/0097

Assignment of Assignor's Interest

Recorded: 2012-02-17 Pages: 15
Assignor
AVENTISUB II INC.
Executed: 2011-03-02
Assignee
CHATTEM INC.
1715 WEST 38TH STREET, CHATTANOOGA, TENNESSEE, 37409
Covered Properties (34)
Novel Intermediates Useful for the Preparation of Antihistaminic Piperidine Derivatives
Patent: 6,242,606 →
Application: 08/275,685 →
Novel Process for Piperidine Derivatives
Patent: 5,631,375 →
Application: 08/369,234 →
Novel Process for Piperidine Derivatives
Patent: 5,675,009 →
Application: 08/431,587 →
Novel Process for Piperidine Derivatives
Patent: 5,644,061 →
Application: 08/432,487 →
Novel Process for Piperidine Derivatives
Patent: 5,618,940 →
Application: 08/432,660 →
Novel Process for Piperidine Derivatives
Patent: 5,652,370 →
Application: 08/432,731 →
Novel Process for Piperidine Derivatives
Patent: 5,654,433 →
Application: 08/433,299 →
Novel Process for Piperidine Derivatives
Patent: 5,650,516 →
Application: 08/433,777 →
Novel Process for Piperidine Derivatives
Patent: 5,663,353 →
Application: 08/434,134 →
Novel Intermediates Useful for the Preparation of Antihistaminic Piperidine Derivatives
Patent: 6,147,216 →
Application: 08/458,747 →
Oral Pharmaceutical Composition of Piperidinoalkanol Compounds in Solution Form
Patent: 5,574,045 →
Application: 08/469,392 →
Stable Pharmaceutical Composition of Terfenadine and Ibuprofen
Patent: 5,691,352 →
Application: 08/624,362 →
Novel Intermediates Useful for the Preparation of Antihistaminic Piperidine Derivatives
Patent: 6,552,200 →
Application: 09/725,259 →
Publication: US 2001/0020114
Novel Intermediates Useful for the Preparation of Antihistaminic Piperidine Derivatives
Patent: 6,566,526 →
Application: 09/725,291 →
Publication: US 2001/0018521
Novel intermediates useful for the preparation of antihistaminic piperidine derivatives
Patent: 6,340,761 →
Application: 09/725,298 →
Novel Intermediates Useful for the Preparation of Antihistaminic Piperidine Derivatives
Patent: 6,555,689 →
Application: 09/726,580 →
Publication: US 2002/0198407
Novel Intermediates Useful for the Preparation of Antihistaminic Piperidine Derivatives
Patent: 6,479,663 →
Application: 09/726,625 →
Publication: US 2001/0000038
Novel Intermediates Useful for the Preparation of Antihistaminic Piperidine Derivatives
Patent: 6,548,675 →
Application: 09/729,203 →
Publication: US 2002/0007085
Novel Intermediates Useful for the Preparation of Antihistaminic Piperidine Derivatives
Patent: 6,559,312 →
Application: 09/731,654 →
Publication: US 2001/0021791
Novel Intermediates Useful for the Preparation of Antihistaminic Piperidine Derivatives
Patent: 6,441,179 →
Application: 09/818,966 →
Publication: US 2002/0077482
Novel intermediates useful for the preparation of antihistaminic piperidine derivatives
Patent: 6,348,597 →
Application: 09/824,788 →
Publication: US 2001/0031895
Novel Antihistaminic Piperidine Derivatives and Intermediates for the Preparation Thereof
Patent: 6,930,197 →
Application: 10/104,097 →
Publication: US 2002/0111513
Novel Antihistaminic Piperidine Derivatives and Intermediates for the Preparation Thereof
Patent: 6,730,791 →
Application: 10/104,149 →
Publication: US 2002/0099088
Novel Antihistaminic Piperidine Derivatives and Intermediates for the Preparation Thereof
Patent: 6,673,933 →
Application: 10/104,277 →
Publication: US 2002/0099077
Novel Antihistaminic Piperidine Derivatives and Intermediates for the Preparation Thereof
Patent: 6,700,012 →
Application: 10/104,311 →
Publication: US 2002/0099090
Novel Antihistaminic Piperidine Derivatives and Intermediates for the Preparation Thereof
Patent: 6,689,898 →
Application: 10/104,783 →
Publication: US 2002/0099091
Novel Antihistaminic Piperidine Derivatives and Intermediates for the Preparation Thereof
Patent: 6,683,094 →
Application: 10/170,050 →
Publication: US 2003/0022919
Novel Intermediates Useful for the Preparation of Antihistaminic Piperidine Derivatives
Patent: 6,777,555 →
Application: 10/364,641 →
Publication: US 2003/0220496
Methods of Treating Allergic Reactions Using an Anhydrous Form of Antihistaminic Piperidine Derivatives
Patent: 7,662,835 →
Application: 11/534,839 →
Publication: US 2007/0021462
Processes for Preparing Anhydrous and Hydrate Forms of Antihistaminic Piperidine Derivatives, Polymorphs and Pseudomorphs Thereof
Application: 11/553,751 →
Publication: US 2007/0129401
Cytoskeletal Active Compounds, Composition and Use
Patent: 7,666,861 →
Application: 11/950,327 →
Publication: US 2008/0076735
A Hydrated Form of an Anthistaminic Piperidine Derivative and Methods of Making a Hydrated Form of an Anthihistaminic Piperidine Derivative
Application: 11/978,669 →
Publication: US 2008/0167469
Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
Application: 11/978,670 →
Publication: US 2008/0167471
Pharmaceutical Composition for Piperidinoalkanol Compounds
Patent: 8,129,408 →
Application: 12/565,410 →
Publication: US 2010/0021547
Related Assignments (22)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name Sep 13, 1996
From: MERRELL DOW PHARMACEUTICALS INC.
To: MERRELL PHARMACEUTICALS INC.
Reel/Frame 008137/0672 →
Change of Name Apr 17, 2006
From: HOECHST MARION ROUSSEL, INC.
To: AVENTIS PHARMACEUTICALS INC.
Reel/Frame 017468/0934 →
Merger May 18, 2006
From: MERRELL PHARMACEUTICALS INC.
To: AVENTIS INC.
Reel/Frame 017636/0297 →
Assignment of Assignor's Interest Nov 16, 2007
From: AVENTIS PHARMACEUTICALS INC.
To: HMR PHARMA INC.
Reel/Frame 020119/0606 →
Change of Name Nov 29, 2007
From: HMR PHARMA INC.
To: AVENTIS HOLDINGS INC.
Reel/Frame 020174/0006 →
Assignment of Assignor's Interest Feb 23, 2010
From: AVENTIS INC.
To: AVENTISUB INC.
Reel/Frame 023973/0163 →
Assignment of Assignor's Interest Feb 24, 2010
From: AVENTISUB INC.
To: AVENTIS HOLDINGS INC.
Reel/Frame 023985/0029 →
Assignment of Assignor's Interest Mar 1, 2010
From: AVENTIS HOLDINGS INC.
To: AVENTISUB II INC.
Reel/Frame 024006/0046 →
Assignment of Assignor's Interest Mar 2, 2010
From: AVENTIS HOLDINGS INC.
To: AVENTISUB II INC.
Reel/Frame 024006/0487 →
Corrective Assignment to Correct the Assignor Previously Recorded on Reel 007253 Frame 0190. Assignor(S) Hereby Confirms the Assignee Confirms Inventors Name Should Be Gianbattista Panzone Not Gianvattista, Pazone.. Jan 25, 2012
From: PANZONE, GIANBATTISTA
To: MERRELL DOW PHARMACEUTICALS INC.
Reel/Frame 027590/0645 →
Assignment of Assignor's Interest Jan 25, 2012
From: CARR, ALBERT A.; RUDISILL, DUANE E.; HAY, DAVID A.
To: MERRELL DOW PHARMACEUTICALS INC.
Reel/Frame 027593/0227 →
Assignment of Assignor's Interest Jan 25, 2012
From: PANZONE, GIANBATTISTA
To: MERRELL DOW PHARMACEUTICALS INC.
Reel/Frame 027593/0345 →
Assignment of Assignor's Interest Jan 25, 2012
From: KRAUSS, RICHARD C.; STROM, ROBERT M.; SCORTICHINI, CAREY L.; KRUPER, WILLIAM J.
To: THE DOW CHEMICAL COMPANY
Reel/Frame 027593/0497 →
Assignment of Assignor's Interest Jan 25, 2012
From: THE DOW CHEMICAL COMPANY
To: MERRELL DOW PHARMACEUTICALS INC.
Reel/Frame 027593/0597 →
Assignment of Assignor's Interest Jan 27, 2012
From: ERTEL, KEITH D.; LONG, DAVID F.
To: MERRELL DOW PHARMACEUTICALS INC.
Reel/Frame 027607/0453 →
Assignment of Assignor's Interest Feb 10, 2012
From: CARR, ALBERT A.; RUDISILL, DUANE E.; HAY, DAVID A.
To: MERRELL DOW PHARMACEUTICALS INC.
Reel/Frame 027687/0891 →
Assignment of Assignor's Interest Feb 10, 2012
From: KING, CHI-HSIN RICHARD; KAMINSKI, MICHELE A.; CHEN, TENG-MAN
To: MERRELL DOW PHARMACEUTICALS INC.
Reel/Frame 027687/0038 →
Merger Feb 13, 2012
From: MERRELL PHARMACEUTICALS INC.
To: AVENTIS INC.
Reel/Frame 027695/0958 →
Change of Name Feb 13, 2012
From: MERRELL DOW PHARMACEUTICALS INC.
To: MERRELL PHARMACEUTICALS INC.
Reel/Frame 027697/0338 →
Assignment of Assignor's Interest Feb 15, 2012
From: AVENTIS INC.
To: AVENTISUB INC.
Reel/Frame 027706/0658 →
Assignment of Assignor's Interest Feb 15, 2012
From: AVENTISUB INC.
To: AVENTIS HOLDINGS INC.
Reel/Frame 027706/0800 →
Assignment of Assignor's Interest Feb 16, 2012
From: AVENTIS HOLDINGS INC.
To: AVENTISUB II INC.
Reel/Frame 027717/0142 →